Related Experiment Video
Updated: May 17, 2026
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
Reduced-intensity conditioning allogeneic stem cell transplantation in pediatric patients and subsequent supportive
Catherine Barrell1, Danielle Dietzen, Zhezhen Jin
1Home Parenteral Nutrition Program, Children's Hospital Boston, MA, USA. barrellc@yahoo.com
Insights
Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation (RIC-AlloHSCT) in children leads to fewer acute toxicities and lower transplantation-related mortality (TRM) compared to myeloablative conditioning (MAC-AlloHSCT). This finding is crucial for improving pediatric patient care and outcomes.
Area of Science:
- Pediatric Hematology
- Oncology
- Transplantation Medicine
Background:
- Allogeneic hematopoietic stem cell transplantation (AlloHSCT) is a critical treatment for pediatric hematologic malignancies and other conditions.
- Myeloablative conditioning (MAC) regimens are associated with significant acute toxicities and supportive care needs.
- Reduced-intensity conditioning (RIC) regimens offer a potentially less toxic alternative.
Purpose of the Study:
- To compare acute toxicities and supportive care requirements between pediatric patients undergoing RIC-AlloHSCT and MAC-AlloHSCT.
- To evaluate 100-day transplantation-related mortality (TRM) as a key outcome measure.
- To identify differences in post-transplantation complications and resource utilization.
Main Methods:
- Retrospective chart and electronic medical records review of 86 pediatric patients who underwent AlloHSCT.
- Comparison of reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation (RIC-AlloHSCT) versus myeloablative conditioning allogeneic hematopoietic stem cell transplantation (MAC-AlloHSCT) groups.
- Statistical analysis including t-tests, chi-square tests, logistic regressions, Kaplan-Meier, log rank, and Cox proportional hazards models.
Main Results:
- Pediatric patients receiving RIC-AlloHSCT demonstrated significantly lower incidence of mucositis, infections, and transfers to the pediatric intensive care unit (PICU) within 30 days post-transplantation.
- RIC-AlloHSCT was associated with reduced need for total parenteral nutrition (TPN) and patient-controlled analgesia (PCA), fewer days with fever, and decreased blood product infusions.
- A statistically significant reduction in 100-day transplantation-related mortality (TRM) was observed in the RIC-AlloHSCT group compared to the MAC-AlloHSCT group.
Conclusions:
- Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation (RIC-AlloHSCT) is associated with significantly lower acute toxicities and transplantation-related mortality (TRM) in pediatric patients compared to myeloablative conditioning (MAC-AlloHSCT).
- These findings underscore the benefit of RIC-AlloHSCT in mitigating immediate post-transplant complications.
- Understanding these differences is vital for nursing staff to effectively educate patients and families and anticipate care needs.
Purpose/Objectives:
To determine if children undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation (RIC-AlloHSCT) have lower incidence of acute toxicities and, subsequently, require less supportive care than is required with myeloablative conditioning (MAC)-AlloHSCT. An additional purpose is to examine later outcomes by comparing 100-day transplantation-related mortality (TRM).
Design:
Retrospective chart and electronic medical records review.
Setting:
A pediatric care center in the northeastern United States.
Sample:
86 patients who underwent AlloHSCT from January 2004 through March 2008.
Methods:
Charts were retrospectively reviewed. The comparison between groups was done by t test (continuous variables) and chi-square test (categorical variables). The logistic regressions, Kaplan-Meier product-limit estimator, log rank test, and Cox proportional hazards model were used.
Main Research Variables:
Days requiring total parenteral nutrition (TPN), patient-controlled analgesia (PCA), incidence of mucositis, days with fevers, number of infections, transfers to pediatric intensive care unit (PICU), blood product infusions, and 100-day TRM, all for 30 days post-transplantation.
Findings:
When comparing pediatric patients undergoing RIC-AlloHSCT (n = 43) versus MAC-AlloHSCT (n = 43) in the first 30 days post-transplantation, a statistically significant decreased incidence was noted for mucositis, infections, transfers to PICU, days on TPN and PCA, and days with fever, as well as 100-day TRM.
Conclusions:
For pediatric patients, RIC-AlloHSCT is associated with significantly lower acute post-transplantation toxicities and TRM than MAC-AlloHSCT.
Implications For Nursing:
For nurses to correctly educate their patients and family members, and to aid nurses in anticipating patient's needs, an understanding of the potential different acute toxicities and supportive care between pediatric patients undergoing RIC- versus MAC-AlloHSCT is vital.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...